Pàgina inicial > Resultats de la cerca: López Díaz de Cerio, Ascensión
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
11 p, 861.1 KB Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS) : A harmonised study protocol for two phase i clinical trials comparing intradermal and intranodal cell administration / Willekens, Barbara (University of Antwerp. Laboratory of Experimental Hematology. Vaccine and Infectious Disease Institute) ; Presas-Rodríguez, Silvia (Universitat Autònoma de Barcelona. Departament de Medicina) ; Mansilla Lopez, Maria Jose (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Derdelinckx, Judith (University of Antwerp. Laboratory of Experimental Hematology. Vaccine and Infectious Disease Institute) ; Lee, Wai-Ping (University Hospital Antwerp (Bèlgica)) ; Nijs, Griet (University Hospital Antwerp (Bèlgica)) ; De Laere, Maxime (University of Antwerp. Laboratory of Experimental Hematology. Vaccine and Infectious Disease Institute) ; Wens, Inez (University of Antwerp . Laboratory of Experimental Hematology. Vaccine and Infectious Disease Institute) ; Cras, Patrick (University Hospital Antwerp (Bèlgica)) ; Parizel, Paul (University Hospital Antwerp (Bèlgica)) ; Van Hecke, Wim (Icometrix NV) ; Ribbens, Annemie (Icometrix NV) ; Billiet, Thibo (Icometrix NV) ; Adams, Geert (C-Clear Partners) ; Couttenye, Marie-Madeleine (University Hospital Antwerp (Bèlgica)) ; Navarro-Barriuso, Juan (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Teniente Serra, Aina (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Quirant, Bibiana (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Lopez-Diaz De Cerio, Ascensión (Clínica Universidad de Navarra) ; Inogés, Susana (Clínica Universidad de Navarra) ; Prosper, Felipe (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ; Kip, Anke (Lygature Utrecht) ; Verheij, Herman (Lygature Utrecht) ; Gross, Catharina C. (University of Munster. Department of Neurology) ; Wiendl, Heinz (University of Munster. Department of Neurology) ; Van Ham, Marieke (University of Amsterdam. Academic Medical Centre-AMC) ; Ten Brinke, Anja (University of Amsterdam. Academic Medical Centre-AMC) ; Barriocanal, Ana María (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Massuet-Vilamajó, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hens, Niel (University of Antwerp. Centre for Health Economic Research and Modelling Infectious Diseases) ; Berneman, Zwi (University of Antwerp. Center for Cell Therapy and Regenerative Medicine) ; Martínez Cáceres, Eva María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Cools, Nathalie (University Hospital Antwerp (Bèlgica)) ; Ramo-Tello, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Introduction Based on the advances in the treatment of multiple sclerosis (MS), currently available disease-modifying treatments (DMT) have positively influenced the disease course of MS. However, the efficacy of DMT is highly variable and increasing treatment efficacy comes with a more severe risk profile. [...]
2019 - 10.1136/bmjopen-2019-030309
BMJ open, Vol. 9, Issue 9 (July 2019) , art. e030309  
Registre complet - Creative Commons
2.
14 p, 516.6 KB Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies / Lord, Phillip (Newcastle University. School of Computing Science) ; Spiering, Rachel (Newcastle University. Institute of Cellular Medicine) ; Aguillon, Juan C. (Universidad de Chile. Instituto de Ciencias Biomédicas (ICBM)) ; Anderson, Amy E. (Newcastle University. Institute of Cellular Medicine) ; Appel, Silke (University of Bergen. Broegelmann Research Laboratory) ; Benítez Ribas, Daniel (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Brinke, Anja ten (Sanquin Research (Amsterdam)) ; Broere, Femke (Utrecht University) ; Cools, Nathalie (University of Antwerp. Vaccine & Infectious Disease Institute) ; Cuturi, Maria Cristina (Center for Research in Transplantation and Immunology (Nantes, França)) ; Diboll, Julie (Newcastle University. Institute of Cellular Medicine) ; Geissler, Edward K. (University Hospital Regensburg. Department of Surgery) ; Giannoukakis, Nick (Institute of Cellular Therapeutics (Pittsburgh, Estats Units d'Amèrica)) ; Gregori, Silvia (San Raffaele Telethon Institute for Gene Therapy (Milà, Itàlia)) ; Ham, S. Marieke van (Sanquin Research (Amsterdam)) ; Lattimer, Staci (Newcastle University. School of Computing Science) ; Marshall, Lindsay (Newcastle University. School of Computing Science) ; Harry, Rachel A. (Newcastle University. Institute of Cellular Medicine) ; Hutchinson, James A. (University Hospital Regensburg. Department of Surgery) ; Isaacs, John D. (Newcastle University. Institute of Cellular Medicine) ; Joosten, Irma (Radboud University Medical Centre) ; Kooten, Cees van (Leiden University Medical Centre) ; López Díaz de Cerio, Ascensión (Clínica Universidad de Navarra) ; Nikolic, Tatjana (Leiden University Medical Centre) ; Oral, Haluk Barbaros (Uludag University. Faculty of Medicine) ; Sofronic Milosavljevic, Ljiljana (University of Belgrade. Institute for the Application of Nuclear Energy) ; Ritter, Thomas (National University of Ireland) ; Riquelme, Paloma (University Hospital Regensburg. Department of Surgery) ; Thomson, Angus W. (University of Pittsburgh School of Medicine) ; Trucco, Massimo (Institute of Cellular Therapeutics (Pittsburgh, Estats Units d'Amèrica)) ; Vives Pi, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Martínez Cáceres, Eva María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Hilkens, Catharien M. U. (Newcastle University. Institute of Cellular Medicine)
Cellular therapies with tolerogenic antigen-presenting cells (tolAPC) show great promise for the treatment of autoimmune diseases and for the prevention of destructive immune responses after transplantation. [...]
2016 - 10.7717/peerj.2300
PeerJ, Vol. 4 (August 2016) , p. e2300  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem